427 related articles for article (PubMed ID: 16751420)
1. Modulation by IL-2 of CD70 and CD27 expression on CD8+ T cells: importance for the therapeutic effectiveness of cell transfer immunotherapy.
Huang J; Kerstann KW; Ahmadzadeh M; Li YF; El-Gamil M; Rosenberg SA; Robbins PF
J Immunol; 2006 Jun; 176(12):7726-35. PubMed ID: 16751420
[TBL] [Abstract][Full Text] [Related]
2. Expression of CD27 and its ligand, CD70, on chronic lymphocytic leukemia B cells.
Ranheim EA; Cantwell MJ; Kipps TJ
Blood; 1995 Jun; 85(12):3556-65. PubMed ID: 7540066
[TBL] [Abstract][Full Text] [Related]
3. Costimulation through the CD137/4-1BB pathway protects human melanoma tumor-infiltrating lymphocytes from activation-induced cell death and enhances antitumor effector function.
Hernandez-Chacon JA; Li Y; Wu RC; Bernatchez C; Wang Y; Weber JS; Hwu P; Radvanyi LG
J Immunother; 2011 Apr; 34(3):236-50. PubMed ID: 21389874
[TBL] [Abstract][Full Text] [Related]
4. Reciprocal expression of CD70 and of its receptor, CD27, in human long term-activated T and natural killer (NK) cells: inverse regulation by cytokines and role in induction of cytotoxicity.
Orengo AM; Cantoni C; Neglia F; Biassoni R; Ferrini S
Clin Exp Immunol; 1997 Mar; 107(3):608-13. PubMed ID: 9067541
[TBL] [Abstract][Full Text] [Related]
5. MART-1-specific melanoma tumor-infiltrating lymphocytes maintaining CD28 expression have improved survival and expansion capability following antigenic restimulation in vitro.
Li Y; Liu S; Hernandez J; Vence L; Hwu P; Radvanyi L
J Immunol; 2010 Jan; 184(1):452-65. PubMed ID: 19949105
[TBL] [Abstract][Full Text] [Related]
6. Augmentation versus inhibition: effects of conjunctional OX-40 receptor monoclonal antibody and IL-2 treatment on adoptive immunotherapy of advanced tumor.
Kjaergaard J; Peng L; Cohen PA; Drazba JA; Weinberg AD; Shu S
J Immunol; 2001 Dec; 167(11):6669-77. PubMed ID: 11714839
[TBL] [Abstract][Full Text] [Related]
7. Requirement for CD70 in CD4+ Th cell-dependent and innate receptor-mediated CD8+ T cell priming.
Taraban VY; Rowley TF; Tough DF; Al-Shamkhani A
J Immunol; 2006 Sep; 177(5):2969-75. PubMed ID: 16920932
[TBL] [Abstract][Full Text] [Related]
8. Stimulation by soluble CD70 promotes strong primary and secondary CD8+ cytotoxic T cell responses in vivo.
Rowley TF; Al-Shamkhani A
J Immunol; 2004 May; 172(10):6039-46. PubMed ID: 15128787
[TBL] [Abstract][Full Text] [Related]
9. Control of established melanoma by CD27 stimulation is associated with enhanced effector function and persistence, and reduced PD-1 expression of tumor infiltrating CD8(+) T cells.
Roberts DJ; Franklin NA; Kingeter LM; Yagita H; Tutt AL; Glennie MJ; Bullock TN
J Immunother; 2010 Oct; 33(8):769-79. PubMed ID: 20842060
[TBL] [Abstract][Full Text] [Related]
10. Antigen-presenting cell-derived signals determine expression levels of CD70 on primed T cells.
Lens SM; Baars PA; Hooibrink B; van Oers MH; van Lier RA
Immunology; 1997 Jan; 90(1):38-45. PubMed ID: 9038710
[TBL] [Abstract][Full Text] [Related]
11. Proliferation response of leukemic cells to CD70 ligation oscillates with recurrent remission and relapse in a low-grade lymphoma.
Kaufmann Y; Amariglio N; Rosenthal E; Hirsch YJ; Many A; Rechavi G
J Immunol; 2005 Nov; 175(10):6940-7. PubMed ID: 16272354
[TBL] [Abstract][Full Text] [Related]
12. The size and phenotype of virus-specific T cell populations is determined by repetitive antigenic stimulation and environmental cytokines.
Gamadia LE; van Leeuwen EM; Remmerswaal EB; Yong SL; Surachno S; Wertheim-van Dillen PM; Ten Berge IJ; Van Lier RA
J Immunol; 2004 May; 172(10):6107-14. PubMed ID: 15128796
[TBL] [Abstract][Full Text] [Related]
13. Involvement of the CD27-CD70 co-stimulatory pathway in allogeneic T-cell response to follicular lymphoma cells.
Schmitter D; Bolliger U; Hallek M; Pichert G
Br J Haematol; 1999 Jul; 106(1):64-70. PubMed ID: 10444164
[TBL] [Abstract][Full Text] [Related]
14. During viral infection of the respiratory tract, CD27, 4-1BB, and OX40 collectively determine formation of CD8+ memory T cells and their capacity for secondary expansion.
Hendriks J; Xiao Y; Rossen JW; van der Sluijs KF; Sugamura K; Ishii N; Borst J
J Immunol; 2005 Aug; 175(3):1665-76. PubMed ID: 16034107
[TBL] [Abstract][Full Text] [Related]
15. CD70 signaling is critical for CD28-independent CD8+ T cell-mediated alloimmune responses in vivo.
Yamada A; Salama AD; Sho M; Najafian N; Ito T; Forman JP; Kewalramani R; Sandner S; Harada H; Clarkson MR; Mandelbrot DA; Sharpe AH; Oshima H; Yagita H; Chalasani G; Lakkis FG; Auchincloss H; Sayegh MH
J Immunol; 2005 Feb; 174(3):1357-64. PubMed ID: 15661893
[TBL] [Abstract][Full Text] [Related]
16. Cutting edge: a critical role for CD70 in CD8 T cell priming by CD40-licensed APCs.
Taraban VY; Rowley TF; Al-Shamkhani A
J Immunol; 2004 Dec; 173(11):6542-6. PubMed ID: 15557144
[TBL] [Abstract][Full Text] [Related]
17. Engagement of CD27 with its ligand CD70 provides a second signal for T cell activation.
Hintzen RQ; Lens SM; Lammers K; Kuiper H; Beckmann MP; van Lier RA
J Immunol; 1995 Mar; 154(6):2612-23. PubMed ID: 7876536
[TBL] [Abstract][Full Text] [Related]
18. CD27-CD27 ligand/CD70 interactions enhance alloantigen-induced proliferation and cytolytic activity in CD8+ T lymphocytes.
Brown GR; Meek K; Nishioka Y; Thiele DL
J Immunol; 1995 Apr; 154(8):3686-95. PubMed ID: 7706711
[TBL] [Abstract][Full Text] [Related]
19. Increased CD8
Zhao S; Zhang Y; Huang G; Luo W; Li Y; Xiao Y; Zhou M; Li Y; Lai J; Li Y; Li B
Blood Cells Mol Dis; 2019 Jul; 77():34-42. PubMed ID: 30953940
[TBL] [Abstract][Full Text] [Related]
20. CD27-CD70 costimulation controls T cell immunity during acute and persistent cytomegalovirus infection.
Welten SP; Redeker A; Franken KL; Benedict CA; Yagita H; Wensveen FM; Borst J; Melief CJ; van Lier RA; van Gisbergen KP; Arens R
J Virol; 2013 Jun; 87(12):6851-65. PubMed ID: 23576505
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
